Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Boi M, Todaro M, Vurchio V, Yang SN, Moon J, Kwee I, et al. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes. Oncotarget. 2016;7(48):79637-79653.

Gaskill N, Guido B, Magro C. Recurrent adult onset Henoch-Schonlein Purpura: a case report. Dermatol Online J. 2016;22(8).

Cushing MM, Asmis L, Calabia C, Rand JH, Haas T. Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma. Transfus Apher Sci. 2016;55(1):114-9.

Pan J-, Sun Y, Jiang Y-, Bott AJ, Jaber N, Dou Z, et al. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. Mol Cell. 2016;62(1):149-51.

Fontugne J, Davis K, Palanisamy N, Udager A, Mehra R, McDaniel AS, et al. Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry. Mod Pathol. 2016;29(2):157-65.

Goel R, Cushing MM, Tobian AA. Pediatric Patient Blood Management Programs: Not Just Transfusing Little Adults. Transfus Med Rev. 2016;30(4):235-41.

Krebs S, Monti S, Seshan S, Fox J, Mannelli L. IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CT. Clin Nucl Med. 2016;41(8):e388-9.

Merkler AE, Duggal I, Kaunzner U, Maciel CB, Miller AM, Scognamiglio T, et al. Rapidly progressive bilateral optic nerve and retinal infarctions due to rhinocerebral mucormycosis and pseudoephedrine use. Neurol Clin Pract. 2016;6(6):549-552.

Jain T, Williams R, Liechty B, Chen LA. Vertebral Metastasis as the Initial Manifestation of Colon Cancer. ACG Case Rep J. 2016;3(4):e122.

Zhou ZN, Tierney C, Rodgers WH, Nguyen L, Fishman D. Ruptured clear cell carcinoma of the ovary presenting as acute abdomen. Gynecol Oncol Rep. 2016;16:1-4.